M Sergon

1PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 29, 2021
High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma.

D Westphal, M Garzarolli, M Sergon

Pageof 1

Frequent Collaborators

1 joint publications

D Westphal

1 joint publications

P Horak

1 joint publications

B Hutter

1 joint publications

S Blum